【レポートの概要（一部）】
1. Report Overview
1.1 Contract Biotech API Manufacturing: World Market Review 2016
1.2 Benefits of this Report
1.2.1 How This Report Delivers
1.2.2 Main Questions Answered by This Analytical Report
1.3 Who is This Report For?
1.4 Methods of the Study
1.5 Frequently Asked Questions (FAQ)
1.6 Some Associated Reports
1.7 About Visiongain
2. Introduction to Biotech API Manufacturing Services
2.1 What are Biotech API Manufacturing Services?
2.1.1 Producing Biotech API: An Overview of the Manufacturing Process
2.1.2 Defining the Biotech API Manufacturing Market
2.1.3 Differing Expression Systems to Manufacture APIs
2.2 Challenges in Manufacturing Biotech API
2.3 Outsourcing: A Common Trend in Biotech API Manufacturing Services
2.4 Future Trends for the Biotech API Manufacturing Services Market
2.5 Glossary
3. Biotech API Manufacturing Services: World Market Outlook and Forecast 2016-2026
3.1 The Contract Biotech API Manufacturing Services Market Performance, 2016
3.1.1 Contract Biotech API Manufacturing Services: Forecast 2015-2026
3.2 Drivers and Restraints in the Biotech API Manufacturing Services Market
3.2.1 Important Drivers in the Biotech API Manufacturing Services Market for the Coming Decade
3.2.1.1 The Ageing Population is a Driver for Growth
3.2.1.2 The Patent Cliff Effect Will Stimulate Biologics and Biosimilar Development
3.2.1.3 Outsourcing as a Driver for Growth
3.2.1.4 Opportunities from the Long Pipeline Will Drive Growth
3.2.1.5 Increased Investment in Orphan Drugs from Companies
3.2.1.6 Emerging Markets Will Grow and Influence the Market
3.2.1.7 Technological Changes: Single-Use Technology Will Become Essential in the Next 10 Years
3.2.2 Restraints on Growth in the Biotech API Manufacturing Services Market
3.2.2.1 Pricing Pressures Will Limit Market Growth
3.2.2.2 Regulatory Restrictions Will Increase
3.2.2.3 Overcapacity Will Be Adverse to Market Growth for CMOs
3.2.2.4 Complexity of API Production is a Challenge
3.3 Outlook for the Outsourced Biotech API Services: Increased Demand
4. Biotech API Manufacturing Services Submarkets: World Market Outlook and Forecasts 2016-2026
4.1 Submarkets for the Biotech API Manufacturing Services Industry
4.1.1 The Mammalian Cell Culture Submarket
4.1.2 The Mammalian Cell Culture Submarket Forecast 2015-2026
4.1.3 ADCs and Next-Generation Antibodies Will Drive Growth 2015-2026
4.1.4 The Microbial Fermentation Submarket
4.1.5 The Microbial Fermentation Submarket Forecast 2015-2026
4.1.5.1 Increase in Demand for Insulin Will Drive Growth 2015-2026
4.1.6 Other APIs Expression Systems Are Still in Development
4.1.6.1 Plant-Made Pharmaceuticals
4.1.6.2 Yeast Cell Expression Systems
4.1.6.3 Insect Cell Expression Systems
4.1.6.4 Other Expression Systems Submarket Forecast 2015-2026
4.2 Chapter Summary: Positive Growth for the Market
5. Biotech API Manufacturing: Outlook for Leading Biological Drug Contract API Sectors: 2015-2026
5.1 Antibody Therapies: An Introduction to the Largest Contract API Biological Drug Sector
5.1.1 Contract API Monoclonal Antibody Manufacturing Forecast 2015-2026
5.1.2 Outlook: Outsourced Manufacturing for Monoclonal Antibody APIs Will Increase
5.2 Contract API Vaccine Manufacturing: A Promising Opportunity for CMOs
5.2.1 Contract API Vaccine Market: Outlook and Forecast 2015-2026
5.2.2 Challenges in Manufacturing Vaccines
5.3 Introduction to the Insulin Therapies Market and Outlook for the Contract API Insulin Therapies Market
5.3.1 Contract API Insulin Analogues Forecast 2015-2026
5.3.2 Insulin Analogues: In-House Production Restrains Contract API Insulin Therapies Market Growth
5.3.3 Development Trends in the Contract API Insulin Market to 2026
5.4 Introduction to the Interferon Therapy Market and Outlook for the Contract API Interferon Therapy Market
5.4.1 Contract API Interferon Market Forecast 2015-2026
5.4.2 Unlikely to be Opportunities in the Contract API Interferon Market
5.5 Introduction to the Growth Hormone Market and Outlook for the Contract API Growth Hormone Manufacturing Market
5.5.1 Contract API Growth Hormone Market Forecast 2015 to 2026
5.5.2 Most Manufacturing is In-House for Growth Hormone Production
5.5.3 Long-Acting Therapies Provide Opportunity for Outsourcing
5.6 Chapter Summary: Outsourcing for Key Biological Products 2015-2026
6. Leading National Markets for Contract Biotech API Manufacturing Services 2015-2026
6.1 Regional Breakdown of the World Biotech API Manufacturing Services Market
6.1.1 US and EU Dominate Growth for Leading National Submarkets 2015-2026
6.1.2 National Revenue Shares by 2026: Emerging Market Growth
6.2 Contract Biotech API Manufacturing in EU Market 2015-2026
6.2.1 Strong Growth for the EU Revenue Forecasts 2015-2026
6.2.2 Forecasts for Switzerland and Leading EU National Revenues 2015-2026
6.2.2.1 Germany Leads the EU Biotech Market with Strong Growth
6.2.2.2 UK: Strong Research Sector Will Drive Market Growth
6.2.2.3 France: Strong Vaccine Development Industry
6.2.2.4 Switzerland: Headquarters for Leading Companies
6.2.2.4.1 Switzerland: Headquarters for Leading Companies
6.2.2.5 Spain: Numerous Biotech Companies
6.2.2.6 Italy: Outlook and Forecast 2015-2026
6.2.3 US: A Market Leader in Biotech API Manufacturing
6.2.4 Japan: A Less Mature Contract Manufacturing Market
6.2.5 BRIC Market: Outlook and Forecasts for Emerging Markets 2015- 2026
6.2.5.1 Emerging Nations May Develop a Presence in the Biologics Market
6.2.5.2 Increased Demand for Biosimilars and Biological Drugs 2015-2026
6.2.5.3 China is Poised for Growth: Forecast for 2015-2026
6.2.5.4 India Offers a Lower-Cost Advantage for Biotech API Manufacturing Services: Forecast 2015-2026
6.2.5.5 Brazilian and Russian Governments Promoting Domestic Biotech Development
6.2.5.6 Russian Biotech API Manufacturing Services Forecast: 2015-2026
6.2.5.7 Brazilian Biotech API Manufacturing Services Forecast: 2015-2026
6.2.6 South Korea: Market Forecast, 2015-2026
6.2.6.1 Leading CMOs Celltrion and Samsung BioLogics Drive the Market
6.2.7 Singapore: Market Forecast, 2015-2026
6.3 Summary of Chapter: Outlook for Leading National Submarkets 2015-2026
7. Leading CMOs in the Biotech API Manufacturing Services Market 2016
7.1 Four Companies Led the Market in 2015
7.2 Leading Companies by Capacity
7.2.1 Small-Scale Biopharmaceutical Manufacturing is a Common Trend
7.2.2 Barriers to Market Entry 2015-2026
7.2.2.1 The High Cost of Facilities: Acquisition as a Cheaper Alternative
7.3 FDA Opens Barriers for the Biosimilars Market
7.4 Boehringer Ingelheim BioXcellence
7.4.1 Strategic Outlook: Expanding into the Asian Market
7.5 Celltrion: Biologics Leader in Asia
7.5.1 Celltrion: Likely Target for Mergers and Acquisitions?
7.6 DSM Biologics: Strategically Increasing Capacity
7.7 Lonza Has the Largest Worldwide Cell Culture Capacity
7.7.1 Lonza: Biopharmaceutical Core Competency as a Strategy for Growth
7.8 Other Market Players of Interest in 2016
7.8.1 Samsung BioLogics: Focusing on Biosimilars
7.8.2 Cytovance Biologics: Plans to Expand
7.8.3 Fujifilm Diosynth Biotechnologies
7.8.3.1 Facility and Service Expansion for the Future
7.9 Leading Biopharma Companies Operate CMO Divisions
7.9.1 AbbVie Contract Manufacturing: Strength through Acquisition
7.9.2 GSK Biopharmaceuticals
7.9.3 Sandoz: Expertise in Biologics and Biosimilars
7.9.4 Rentschler Biotechnologie: Recent Expansions
7.10 Teva: A Future Player in the Biologics Market
7.11 Catalent Offers a New Platform through Partnership
7.12 Chapter Summary: Leading Companies 2015-2026
8. Biotech API Manufacturing Services Market Industry Trends 2015-2026: Qualitative Analysis
8.1 SWOT Analysis: Strengths and Weaknesses of the Biotech API Manufacturing Services Market 2016
8.1.1 Biopharmaceutical Demand for Outsourcing is Increasing
8.1.2 A Fragmented Market with a Costly and Difficult Manufacturing Process
8.2 Opportunities for the Biotech API Manufacturing Services Market 2015-2026
8.3 Threats for the Biotech API Manufacturing Services Market 2015-2026
8.4 STEP Analysis of the Biotech API Manufacturing Services Market
8.4.1 Social Factors: Drug Pricing Pressures to Meet Demand for an Increasing Ageing Population
8.4.2 Technological Factors: Advances Will Drive Growth
8.4.2.1 Single-Use Technology: A Vital Trend for the Future
8.4.3 Economic Factors: The High Cost of Manufacturing Will Lead to Outsourcing
8.4.4 Political Factors: Regulatory Requirements Need to Be Met
8.5 Trends in Biological Drug Development 2015-2026
8.5.1 Biosimilars Will Be an Important Opportunity for CMOs
8.5.2 CMOs are Investing in Next-Generation Antibody Development
8.5.3 Orphan Drugs and Personalised Medicine: Trend for Smaller Batches
8.5.4 Outlook for Single-Use Technologies in Biotech API Manufacturing 2015-2026
8.5.4.1 Future Direction: Single-Use Systems Will be Essential
8.5.5 Outsourcing Trends for Biotech API Manufacturing 2015-2026
8.5.5.1 Biopharma Companies Continue to Invest in In-House Facilities
8.5.5.2 Off-shoring Biotech API Manufacturing to Emerging Markets: Not a Trend for this Decade?
8.5.5.3 Overcapacity is a Risk for the Biotech CMO Industry
8.5.5.4 Future Trends: Strategic Partnering
8.5.5.5 Alternative Expression Methods
8.6 Regulations and Effects on the Biotech API Manufacturing Services Industry
8.6.1 Effect on the Emerging Biotech API Manufacturing Services Market 2015-2026
8.6.2 Regulations in Other Countries in the Biotech API Market
8.7 Chapter Summary: Industry Trends for Contract Biotech API Manufacturing to 2026
9. Research Interviews
9.1 Interview with Mr Steve Bagshaw, Chief Executive Officer, FUJIFILM Diosynth Biotechnologies (Fujifilm)
9.1.1 Novel Expression Platforms
9.1.2 Expanding Manufacturing Capacity
9.1.3 Acquisition of KalonBiotherapeutics – Effects on Business?
9.1.4 Over-capacity – A Realistic Threat to API Manufacturing CMOS?
9.1.5 Future Opportunities for the API Manufacturing CMO Market
9.2 Interview with Mr Jon S. Gingrich, Manager, Business Development, Avid Bioservices Inc., California, USA
9.2.1 Avid Bioservices
9.2.2 The Influence of Biosimilars on the Current Biotech API Manufacturing Services Market for CMOs
9.2.3 Competition in the US Biotech API Manufacturing Services Market
9.2.4 The Challenges of API Manufacturing
9.2.5 Avid Bioservices Strategies for Growth in the Biotech API Manufacturing Services Market
10. Conclusions
10.1 The Contract Biotech API Manufacturing Services Market
10.2 Outlook for the Biotech API Manufacturing Services Market
10.2.1 Mammalian Cell Culture is the Leading Expression Platform for Outsourced Biotech API Manufacturing
10.2.2 The US and EU Markets Lead for the Global Biotech API Manufacturing Services Market in 2015
10.2.3 Single-Use Technology Will Become Indispensable for Success in the Market
10.3 Growth in the Market 2015-2026
10.3.1 The Future of the Biotech API Manufacturing Services Marketplace
【レポート販売概要】
■ タイトル：生物学的製剤API（原薬）製造サービスの世界市場予測2016-2026■ 英文：Biological Drug API Manufacturing Services World Industry and Market Predictions 2016-2026
■ 発行日：2016年8月
■ 調査会社：visiongain
■ 商品コード：VGAIN81916
■ 調査対象地域：グローバル
- 世界のカプノグラフィー市場動向（2012-2016）TechNavio's analysts forecast the Global Capnography market to grow at a CAGR of 20.17 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of portable capnographs. The market has also been witnessing increasing adoption of Microstream capnography. However, the lack of product differentiation could pose a challenge to the growth of …
- コンテナオーケストレーションの世界市場：構成要素別（プラットフォーム＆サービス）、組織規模別（大企業＆中小企業）、業種別（BFSI、政府、IT＆テレコム、小売、ヘルスケア、その他）Application containerization is an OS-level virtualization method to deploy and run distributed applications without launching an entire virtual machine for each app. Container orchestration manage the lifecycles of these containers along with the deployment, scaling & descaling, as well as their load balancing. Container orchestration ensures redundancy and availability of containers along with a …
- 内視鏡：現在および将来プレイヤーEndoscopy - Current and Future Players Summary The Endoscopy market in Europe is a dynamic market that is expected to grow through 2021. The market is also very saturated with intense competition due to the availability of similar product offerings across market players. In the face of increasing hospital consolidation into one network and the trend of oligopoly purchasing, i.e. purchasing more pr …
- 追跡ソリューションの世界市場予測（～2021年）：バーコードスキャナ、プラントマネジャー、ラベリング、モニタリング＆検証The global healthcare track and trace solutions market is estimated to reach USD 2.81 Billion by 2021, at a CAGR of 17.3% during the forecast period. The increasing focus of manufacturers on brand protection and growth in number of packaging-related product recalls are driving market growth. The rising number of manufacturing facilities in developing regions presents significant growth opportuniti …
- タンブラーの世界市場展望2017-2026According to Stratistics MRC, the Global Tumblers Market is accounted for $2.10 billion in 2017 and is expected to reach $4.19 billion by 2026 growing at a CAGR of 8.0% during the forecast period. The increasing beverage industry, on-the-go drinkware, increasing outdoor activities, and growing health & fitness concerns are some of the factors fuelling market growth. However, the cost of tumblers c …
- 世界のHetNetエコシステム（スモールセル、キャリアWiFi、C-RAN、DAS）Driven by in-building wireless coverage requirements and the growing influx of mobile broadband data traffic, a traditional macrocell based cellular network deployment is not deemed to be a sufficient solution to address the coverage and capacity needs of today’s wireless subscribers. Wireless carriers are thus increasing their investments in Heterogeneous Network or HetNet infrastructure such as …
- 世界のヘテロジニアス・モバイル処理及びコンピューティング市場：プロセッサ、グラフィック処理ユニット、DSP、接続ソリューション等Heterogeneous mobile processing (HMP) and computing defines the architecture in which processors, DSPs (Digital Signal Processor), GPUs (Graphic Processing Units), connectivity solutions (Wi-Fi, Bluetooth), and software are being integrated to accelerate the performance and computational abilities of System on Chip (SoC). These entire components work simultaneously to improve the performance and s …
- ガラス製包装容器（パッケージ）の世界市場2015-2019About glass packaging Glass packaging is used in the packaging of F&B, pharmaceuticals, chemicals, and cosmetics. Glass bottles and jars can be molded into a variety of shapes and dimensions. Its inert nature and ability to preserve products over a long period of time makes glass a popular choice for packaging in the F&B industry. Glass provides the aesthetic appeal required for certain products t …
- 世界の自律駐車市場：Global Autonomous Parking Market 2014-2018TechNavio's analysts forecast the Global Autonomous Parking market to grow at a CAGR of 19.39 percent over the period 2013-2018. One of the key factors contributing to this market growth is the enhanced driver experience provided by the system. The Global Autonomous Parking market has also been witnessing growing focus towards driverless vehicles. However, the diversity in the amount of automation …
- 自動車用エネルギー回生システムの世界市場：回生ブレーキ、排熱回収システム（排気ガス再循環(EGR)、ターボチヤージャー）、運動エネルギー回生システムAn automotive energy recovery system is the one that harnesses the energy created by various functions of an automobile instead of letting it dissipate. This energy is then transformed and stored for immediate or later use. The recovered energy can be used to provide additional power to the engine or for the functioning of the vehicles’ axillaries. The usage of the energy recovery systems in the c …
- 人数計測システムの世界市場予測（～2022）：技術別（赤外線、ビデオベース、熱画像）、用途別、地域別The people counting system market is expected to be worth USD 1,637.4 Million by 2022, at a CAGR of 18.9% between 2016 and 2022. The growth of this market is propelled by the growing retail sector and increase in adoption rate of people counting systems, availability of economical and easy-to-install solutions, and increasing demand from transportation sector for people counting solutions. The adv …
- 可視光通信（VLC）の世界市場2015-2019Technavio expects the global visible light communication (VLC) market to grow at a very optimistic rate, posting a CAGR of almost 64% during the forecast period. Visible light communication is a wireless technology that uses light emanated by LED bulbs to provide a network for high-speed communication parallel to Wi-Fi. This technology is a faster and cheaper optical version of Wi-Fi. The market g …
- 食品用酵素の世界市場：カルボヒドラーゼ、プロテアーゼ、リパーゼAbout Food Enzymes Food enzymes are catalysts of biochemical reactions that break down complex starch, fat, and large protein molecules into smaller units. They are derived from various sources such as plant tissue, animal tissue, and microorganisms. They are widely used in food and beverage products to aid digestive and metabolic processes. Based on type, food enzymes are segmented into carbohydr …
- 産業用パネルコンピュータの世界市場ABSTRACTAbout Industrial Panel PC Industrial panel PCs are incorporated with an LCD, motherboard, and other electronic components in the same enclosure. These panel PCs assimilate touchscreens for user interaction. They are used in manufacturing and non-manufacturing industries. These panel PCs are used in automation systems integration, smart buildings, process and discrete manufacturing, HMI, sm …
- LTE端末データベース：ベンダー、出荷量、売上、加入者数（LTE Devices Database: Vendor Device Launches, Shipments, Revenues & Subscriptions by Region and Country: 2011-2015）LTE device shipments reached 8 million units at the end of 2011. With most vendors going full swing into the LTE, the LTE devices market is set to grow at a CAGR of over 104 % over the next five years reaching 300 million shipments by 2016. 2012 alone will see shipments increase to 32 million units. From a regional perspective North America will continue to lead the market in terms of shipments. H …
